0001104659-22-007324.txt : 20220125
0001104659-22-007324.hdr.sgml : 20220125
20220125135015
ACCESSION NUMBER: 0001104659-22-007324
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220124
FILED AS OF DATE: 20220125
DATE AS OF CHANGE: 20220125
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Stephan Dietrich A
CENTRAL INDEX KEY: 0001774588
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35963
FILM NUMBER: 22552824
MAIL ADDRESS:
STREET 1: 213 SMITHFIELD ST
CITY: PITTSBURGH
STATE: PA
ZIP: 15222
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NeuBase Therapeutics, Inc.
CENTRAL INDEX KEY: 0001173281
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 465622433
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0930
BUSINESS ADDRESS:
STREET 1: 700 TECHNOLOGY DRIVE
CITY: PITTSBURGH
STATE: PA
ZIP: 15219
BUSINESS PHONE: 6464501790
MAIL ADDRESS:
STREET 1: 700 TECHNOLOGY DRIVE
CITY: PITTSBURGH
STATE: PA
ZIP: 15219
FORMER COMPANY:
FORMER CONFORMED NAME: Ohr Pharmaceutical Inc
DATE OF NAME CHANGE: 20090819
FORMER COMPANY:
FORMER CONFORMED NAME: BBM HOLDINGS, INC.
DATE OF NAME CHANGE: 20070402
FORMER COMPANY:
FORMER CONFORMED NAME: PRIME RESOURCE INC
DATE OF NAME CHANGE: 20020513
4
1
tm224291-1_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2022-01-24
0
0001173281
NeuBase Therapeutics, Inc.
NBSE
0001774588
Stephan Dietrich A
C/O 350 TECHNOLOGY DRIVE, FOURTH FLOOR
PITTSBURGH
PA
15219
1
1
1
0
President and CEO
Employee Stock option (right to buy)
1.58
2022-01-24
4
A
0
306000
0
A
2032-01-24
Common Stock
306000
306000
D
25% of the total shares shall vest on the first anniversary of January 24, 2022, and the remaining shares shall vest on an equal monthly basis over the following 36 months; provided that vesting shall only occur on a scheduled vesting date if employment has not terminated prior to such vesting date.
/s/ Dietrich A. Stephan
2022-01-25